Skip to main content
Intermediate Technical In the Industry Vocabulary Test

targeted therapy

Precision cancer treatment directed at specific molecular targets or genetic mutations in tumor cells.

Full Definition

Targeted therapy in thoracic oncology refers to treatments that specifically target molecular abnormalities or genetic mutations present in cancer cells, offering a more precise approach than traditional chemotherapy. Common targets in lung cancer include EGFR mutations, ALK rearrangements, ROS1 fusions, BRAF mutations, and others. These therapies typically involve small molecule inhibitors or monoclonal antibodies that block specific pathways essential for cancer cell growth and survival. Targeted therapy often provides better efficacy and tolerability compared to chemotherapy in patients whose tumors harbor the corresponding molecular targets, but resistance typically develops over time, requiring sequential treatment strategies.

Usage

Usage note: Specify the target when known (EGFR-targeted, ALK-targeted); distinguish from immunotherapy.

In Context

  • "The patient achieved excellent response to targeted therapy with osimertinib for EGFR-mutated lung cancer." — Treatment response note
  • "Comprehensive genomic profiling is essential for identifying candidates for targeted therapy." — Molecular testing protocol

Also known as

precision medicine molecular targeted therapy

Contrasted with

chemotherapy cytotoxic therapy

Don't confuse with

immunotherapy personalized medicine

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON